Clearside Biomedical (CLSD) Stock Chart & Stock Price History → The biggest energy story ever? (From Porter & Company) (Ad) Free CLSD Stock Alerts $1.27 +0.01 (+0.79%) (As of 05/1/2024 ET) Add Compare Share Share ChartStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media Clearside Biomedical Stock Price Performance5 Day Performance-5.22%1 Month Performance-9.29%3 Month Performance-7.30%6 Month Performance+58.75%Year-To-Date Performance+8.55%1 Year Performance+29.61% Receive CLSD Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Clearside Biomedical and its competitors with MarketBeat's FREE daily newsletter Email Address Ad Porter & CompanyTrump’s last act as President You’ve probably never heard of Executive Order #13972. Signed by President Trump just days before leaving office, it greenlit what could be the most revolutionary technology of the decade… yet it has nothing to do with AI, blockchain, or mRNA vaccines. For the full story, click here. CLSD Stock Chart for Thursday, May, 2, 2024 CLSD Chart by TradingView Clearside Biomedical Share Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization05/01/2024$1.26$1.27+0.79%$1.34$1.2584,686 shs$94.89 million04/30/2024$1.29$1.26-2.33%$1.33$1.25111,464 shs$94.15 million04/29/2024$1.34$1.29-3.73%$1.35$1.28110,674 shs$96.39 million04/26/2024$1.26$1.34+6.35%$1.38$1.27154,107 shs$100.13 million04/25/2024$1.34$1.26-5.97%$1.34$1.26135,231 shs$94.15 million04/24/2024$1.37$1.34-2.19%$1.45$1.29201,248 shs$100.13 million Get the Latest News and Ratings for CLSD and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Clearside Biomedical and its competitors with MarketBeat's FREE daily newsletter. 04/23/2024$1.41$1.37-2.84%$1.47$1.35232,156 shs$102.37 million04/22/2024$1.31$1.41+7.63%$1.46$1.29299,006 shs$105.36 million04/19/2024$1.32$1.31-0.76%$1.45$1.26228,016 shs$97.88 million04/18/2024$1.26$1.32+4.76%$1.39$1.24329,091 shs$98.63 million04/17/2024$1.15$1.26+9.57%$1.27$1.11329,243 shs$94.15 million04/16/2024$1.29$1.15-10.85%$1.27$1.15331,932 shs$85.93 million04/15/2024$1.25$1.29+3.20%$1.30$1.21184,217 shs$96.39 million04/12/2024$1.30$1.25-3.85%$1.34$1.24372,476 shs$93.40 million04/11/2024$1.24$1.30+4.84%$1.34$1.23181,624 shs$97.14 million04/10/2024$1.29$1.24-3.88%$1.32$1.23183,201 shs$92.65 million04/09/2024$1.29$1.29$1.35$1.20307,019 shs$96.39 million04/08/2024$1.30$1.29-0.77%$1.37$1.22304,784 shs$96.39 million04/05/2024$1.33$1.30-2.26%$1.40$1.28518,859 shs$97.14 million04/04/2024$1.43$1.33-6.99%$1.43$1.33144,309 shs$99.38 million04/03/2024$1.40$1.43+2.14%$1.45$1.31189,891 shs$106.85 million04/02/2024$1.58$1.40-11.39%$1.63$1.23720,336 shs$104.61 million04/01/2024$1.53$1.58+3.27%$1.61$1.50232,986 shs$118.06 million03/29/2024$1.53$1.53$1.73$1.50442,691 shs$114.32 million03/28/2024$1.67$1.53-8.38%$1.72$1.50442,364 shs$114.32 million03/27/2024$1.69$1.67-1.18%$1.76$1.56520,735 shs$124.78 million03/26/2024$1.73$1.69-2.31%$1.76$1.63203,051 shs$126.28 million03/25/2024$1.71$1.73+1.17%$1.78$1.68177,614 shs$129.27 million03/22/2024$1.80$1.71-5.00%$1.80$1.67239,738 shs$127.77 million03/21/2024$1.63$1.80+10.43%$1.80$1.63571,105 shs$134.50 million03/20/2024$1.63$1.63$1.68$1.55592,626 shs$121.79 million03/19/2024$1.56$1.63+4.49%$1.67$1.52368,734 shs$121.79 million03/18/2024$1.71$1.56-8.77%$1.78$1.49858,029 shs$116.56 million03/15/2024$1.73$1.71-1.16%$1.83$1.69552,152 shs$127.77 million03/14/2024$1.63$1.73+6.13%$1.93$1.61852,859 shs$110.05 million03/13/2024$1.64$1.63-0.61%$1.91$1.63850,414 shs$103.68 million03/12/2024$2.02$1.64-18.81%$2.12$1.581.12 million shs$104.32 million03/11/2024$1.67$2.02+20.96%$2.07$1.641.28 million shs$128.49 million03/08/2024$1.67$1.67$1.87$1.66794,349 shs$106.23 million03/07/2024$1.51$1.67+10.60%$1.74$1.572.98 million shs$106.23 million😱 This phenomenon is smashing regular market gains (Ad)Thanks to a little-known “Pathfinder” trading phenomenon… Traders have recently unlocked one of the most powerful idea-generation sources in the history of trading. At every single market open.Click here to save your seat and join the next LIVE workshop!03/06/2024$1.39$1.51+8.63%$1.65$1.351.67 million shs$96.05 million03/05/2024$1.39$1.39$1.40$1.3574,857 shs$88.42 million03/04/2024$1.39$1.39$1.40$1.33135,675 shs$88.42 million03/01/2024$1.40$1.39-0.71%$1.43$1.3571,765 shs$88.42 million02/29/2024$1.41$1.40-0.71%$1.43$1.36132,585 shs$89.05 million02/28/2024$1.40$1.41+1.08%$1.44$1.36327,197 shs$89.69 million02/27/2024$1.34$1.40+4.10%$1.44$1.30377,271 shs$88.74 million02/26/2024$1.36$1.34-1.47%$1.37$1.3093,091 shs$85.24 million02/23/2024$1.33$1.36+2.26%$1.37$1.28148,568 shs$86.51 million02/22/2024$1.30$1.33+2.31%$1.33$1.28125,774 shs$84.60 million02/21/2024$1.29$1.30+0.78%$1.34$1.2181,894 shs$82.69 million02/20/2024$1.25$1.29+3.20%$1.30$1.20123,372 shs$82.06 million02/19/2024$1.25$1.25$1.28$1.20101,600 shs$79.51 million02/16/2024$1.22$1.25+2.46%$1.28$1.2096,367 shs$79.51 million02/15/2024$1.23$1.22-0.81%$1.29$1.17163,465 shs$77.60 million02/14/2024$1.30$1.23-5.38%$1.40$1.21211,794 shs$78.24 million02/13/2024$1.38$1.30-5.80%$1.40$1.2089,295 shs$82.69 million02/12/2024$1.42$1.38-2.82%$1.43$1.32217,213 shs$86.12 million02/09/2024$1.38$1.42+2.90%$1.46$1.37225,156 shs$88.62 million02/08/2024$1.38$1.38$1.41$1.35130,374 shs$86.13 million02/07/2024$1.41$1.38-2.13%$1.41$1.3579,470 shs$88.00 million02/06/2024$1.39$1.41+1.44%$1.43$1.3752,958 shs$88.00 million02/05/2024$1.37$1.39+1.46%$1.42$1.3554,526 shs$86.75 million02/02/2024$1.33$1.37+3.01%$1.38$1.3181,024 shs$85.50 million02/01/2024$1.25$1.33+6.40%$1.33$1.2558,723 shs$83.01 million Related Companies: Oramed Pharmaceuticals Stock Chart Anixa Biosciences Stock Chart BioXcel Therapeutics Stock Chart Allakos Stock Chart PMV Pharmaceuticals Stock Chart OptiNose Stock Chart Cue Biopharma Stock Chart IO Biotech Stock Chart DiaMedica Therapeutics Stock Chart Eton Pharmaceuticals Stock Chart Receive CLSD Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Clearside Biomedical and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:CLSD) was last updated on 5/2/2024 by MarketBeat.com Staff From Our PartnersAI finds its first serious applicationWall Street StarHave You Seen Elon’s New A.I. Device? (Picture Inside)InvestorPlaceHealthcare Takes A Big Step Forward With The Help Of AIThe Bull ReportBiden to Launch “FedNOW” [Move Your Money Now]Priority GoldA.I. is a Tidal Wave - Here’s What to BuyChaikin Analytics😱 This phenomenon is smashing regular market gainsMillPubYour bank is lying to you.MyBankTrackerDollar CancelledLear Capital Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Clearside Biomedical, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.